(VIANEWS) – The NASDAQ ended the session with Castle Biosciences (CSTL) jumping 4.15% to $30.97 on Thursday while NASDAQ jumped 0.41% to $12,720.58.
Today’s last reported volume for Castle Biosciences is 123468, 62.05% below its average volume of 325370.
Castle Biosciences’s last close was $29.73, 62.17% under its 52-week high of $78.58.
The company’s growth estimates for the ongoing quarter and the next is a negative 114.3% and a negative 68.1%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Castle Biosciences’s stock is considered to be oversold (<=20).
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $30.97 at 18:29 EST, way under its 52-week high of $78.58 and way above its 52-week low of $15.58.
Castle Biosciences’s Moving Average
Castle Biosciences’s worth is way above its 50-day moving average of $22.43 and way below its 200-day moving average of $36.79.
More news about Castle Biosciences (CSTL).